Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Therapeutic Drug Monitoring|December 18, 2013
Immediate cooling does not prevent the ex vivo hydrolysis of L-asparagine by asparaginaseClaudia Lanvers-Kaminsky, Petra Schulze Westhoff, Maurizio DʼIncalci, et al.
Pediatric Blood & Cancer|May 7, 2011
Methodological and ethical aspects of randomized controlled clinical trials in minors with malignant diseasesLillian G Rothenberger, Andreas Dirk Henschel, Dominik Schrey, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2011
Physiologically based pharmacokinetic modelling of high- and low-dose etoposide: from adults to childrenGisela Kersting, Stefan Willmann, Gudrun Würthwein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2011
Population pharmacokinetics of busulfan in children: increased evidence for body surface area and allometric body weight dosing of busulfan in childrenMirjam N Trame, Martin Bergstrand, Mats O Karlsson, et al.
Plos One|February 17, 2017
Objectively measured versus self-reported physical activity in children and adolescents with cancerMiriam Götte, Corinna Caroline Seidel, Sabine Verena Kesting, et al.
Analytical Biochemistry|October 17, 2002
Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of L-asparaginase in human serumClaudia Lanvers, Joao Paulo Vieira Pinheiro, Georg Hempel, et al.
Anti-Cancer Drugs|October 11, 2003
The bisphosphonate pamidronate is a potent inhibitor of Ewing's sarcoma cell growth in vitroJürgen Sonnemann, Vera Eckervogt, Borna Truckenbrod, et al.
Pediatric Blood & Cancer|February 22, 2011
Five-year single-center study of asparaginase therapy within the ALL-BFM 2000 trialDominik Schrey, Katharina Speitel, Claudia Lanvers-Kaminsky, et al.
Pageof 10